MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide

Journal of Molecular Neuroscience

Volumn 47, Issue 2, 2012, Pages 346-356

  Zhang, Shuguang ^a   Wan, Yi ^b   Pan, Tianhong ^a   Gu, Xiaoyan ^c   Qian, Chunfa ^d   Sun, Guan ^e   Sun, Lihua ^d   Xiang, Yangzheng ^d   Wang, Zhimin ^b   Shi, Lei ^a  

^a JIANGSU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c 454th Hospital of Chinese PLA   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Bax; Bcl 2; MicroRNA; Temozolomide

Indexed keywords

CASPASE 3; MICRORNA 21; PROTEIN BAX; PROTEIN BCL 2; TEMOZOLOMIDE;

APOPTOSIS; ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; STEM CELL; THERAPY EFFECT;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL LINE, TUMOR; DACARBAZINE; GLIOBLASTOMA; HUMANS; MICRORNAS;

MAMMALIA;

EID: 84863869068     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9759-8     Document Type: Article

References (31)

1. Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P (2005) Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 23:2372-2377 (Pubitemid 46218731)
2. Beier D, RÖhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP (2008) Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 68(14):5706-5715
3. Bojes HK, Suresh PK, Mills EM, Spitz DR, Sim JE, Kehrer JP (1998) Bcl-2 and Bcl-xL in peroxide-resistant A549 and U87MG Cells. Tohcol Sci 42:109-116 (Pubitemid 28211139)
4. Cartron P, Oliver L, Martin S, Moreau C, LeCabellec M, Jezequel P, Meflah K, Vallette FM (2002) The expression of a new variant of the pro-apoptotic molecule Bax, Bax, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet 11:675-687 (Pubitemid 34285139)
5. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033 (Pubitemid 40994386)
6. Chen C, Ridzon DA, Broomer AJ, Zhou ZH, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of micro-RNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179
7. Clarke MJ, Mulligan EA, Grogan PT, Mladek AC, Carlson BL, Schroeder MA, Curtin NJ, Lou Z, Decker PA, Wu W, Plummer ER, Sarkaria JN (2009) Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines. Mol Cancer Ther 8:407-414
8. Das A, Banik NL, Patel SJ, Ray SK (2004) Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 3:36
9. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H (2005) Stem cell division is regulated by the microRNA pathway. Nature 435:974-978 (Pubitemid 40896325)
10. Hirose Y, Berger MS, Pieper RO (2001) p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61:1957-1963 (Pubitemid 32692013)
11. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH (2004) Apoptotic proteins in the temporal cortex in schizophrenia: high bax/bcl-2 ratio without caspase-3 activation. Am J Psychiatry 161:109-115 (Pubitemid 38419315)
12. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D,Wilson M,Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ (2007) The let-7 microrna represses cell proliferation pathways in human cells. Cancer Res 67:7713-7722 (Pubitemid 47281364)
13. Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH (2006) Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas. Oncol Rep 16:33-39
14. Kobayashi T, Masumoto J, Tada T, Nomiyama T, Hongo K, Nakayama J (2007) Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas. Clin Cancer Res 13:3868-3874 (Pubitemid 47037593)
15. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008
16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 25:402-408 (Pubitemid 34164012)
17. Manero F, Gautier F, Gallenne T, Cauquil N, Grée D, Cartron P, Geneste O, Grée R, Vallette FM, Juin P (2006) The small organic compound ha14-1 prevents bcl-2 interaction with bax to sensitize malignant glioma cells to induction of cell death. Cancer Res 66:2757-2764
18. Mishra PJ, Bertino JR (2009) MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10:399-416
19. Narayan P, Mentzer RM Jr, Lasley RD (2001) Annexin V staining during reperfusion detects cardiomyocytes with unique properties. Am J Physiol Heart Circ Physiol 281:H1931-H1937
20. Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68:8164-8172
21. Qin W, Zhao B, Shi Y, Yao C, Jin L, Jin Y (2009) BMPRII is a direct target of miR-21. Acta Biochim Biophys Sin 41:618-623
22. Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX, Jia ZF, Xu P, Pu PY, Kang CS (2010a) MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 10:27
23. Ren Y, Kang CS, Yuan XB, Zhou X, Xu P, Han L, Wang GX, Jia Z, Zhong Y, Yu S, Sheng J, Pu PY (2010b) Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed 21:303-314
24. Rukov JL, Vinther J, Shomron N (2011) Pharmacogenomics genes show varying perceptibility to microRNA regulation. Pharmacogenet Genomics 21:251-262
25. Ryan KM, Phillips AC, Vousden KH (2001) Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13:332-337 (Pubitemid 32429498)
26. Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D (2007) Increased Bax/Bcl-2 ratio upregulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 21:123-132 (Pubitemid 46359209)
27. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y (2008) hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236:185-193
28. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z (2010) MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing BaxBcl-2 ratio and caspase-3 activity. Brain Res 1352:255-264
29. Shinoura N, Yoshida Y, Nishimura M, Muramatsu Y, Asai A, Kirino T, Hamada H (1999) Expression level of bcl-2 determines anti- or proapoptotic function. Cancer Res 59:4119-4128 (Pubitemid 29393587)
30. Shomron N (2010) MicroRNAs and pharmacogenomics. Pharmacogenomics 11:629-632
31. Stupp R, Tonn JC, Brada M, Pentheroudakis G (2010) High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Onc 21:v190-v193